Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Supplies and Components Index
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • MedTech Resources
    • Medtech Events in 2025
    • The 2024 Medtech Big 100
    • Medical Device Handbook
    • MedTech 100 Index
    • Subscribe to Print Magazine
    • DeviceTalks
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Podcasts
    • Print Subscription
    • Webinars / Digital Events
    • Whitepapers
    • Voices
    • Video
  • 2025 Leadership
    • 2024 Winners
    • 2023 Winners
    • 2022 Winners
    • 2021 Winners
  • Women in Medtech
  • Advertise
  • Subscribe

Acelity introduces ALLODERM SELECT DUO Regenerative Tissue Matrix

October 26, 2016 By Abigail Esposito

fs_380x380_alloderm_fd0

ALLODERM Regenerative Tissue Matrix is a biological tissue matrix for soft tissue reinforcement in breast reconstruction procedures, with more than 1.4 million implants to date.

Acelity, a global advanced wound care and regenerative medicine company, announced that ALLODERM SELECT DUOTM Regenerative Tissue Matrix is now available in the U.S.

ALLODERM Regenerative Tissue Matrix is a biological tissue matrix for soft tissue reinforcement in breast reconstruction procedures, with more than 1.4 million implants to date. The new offering is a matched tissue matrix pair intended for patients undergoing bilateral breast reconstruction that provides uniform tissue characteristics, including same donor, shape and thickness, allowing for a more consistent product experience for both plastic surgeons and patients.

“Reconstruction is an important part of the recovery process for many women who undergo mastectomy,” said Allen Gabriel, M.D., board-certified plastic surgeon at PeaceHealth Medical Group Plastic Surgery, Vancouver, Washington. “The ALLODERM SELECT DUO Tissue Matrix is an enhanced product offering for bilateral breast reconstruction, which are approximately 60% of all breast reconstructions performed. The matched pair from a single donor helps surgeons achieve their desired surgical outcomes and advances the art and practice of this critical component to women’s restoration and well being.”

ALLODERM SELECT DUO Regenerative Tissue Matrix delivers the regenerative qualities that surgeons have come to trust, while offering uniform tissue characteristics to better improve the bilateral breast reconstruction experience.

Products in the ALLODERM Tissue Matrix portfolio are made from donated human dermis, processed to remove cells while preserving the essential biological components and structure of the dermal matrix to support tissue regeneration. Acelity uses proprietary processing that allows the matrices to support rapid revascularization, cell repopulation and white cell migration, offering surgeons a natural solution for soft tissue support where weakness exists.

This launch marks the third product advancement to the Acelity breast reconstruction portfolio in 2016. In May, Acelity launched the ALLODERM SELECT Regenerative Tissue Matrix brand that provides a consistent shape resulting from advanced cutting technology, a range of thicknesses to meet clinical needs (thin, medium, thick and x-thick), and an innovative packaging design that ensures consistently smooth and straight pieces.

ALLODERM SELECT DUO is available in the updated thicknesses and improved packaging. In addition to ALLODERM SELECT and ALLODERM SELECT DUO Tissue Matrices, Acelity has initiated a limited launch of the ARTIA Reconstructive Tissue Matrix, a new porcine acellular dermal matrix, in the U.S. and full launch in Europe.

“For more than 20 years, surgeons have relied on ALLODERM Tissue Matrix as a leading product in breast reconstruction, and Acelity is committed to further advancing this technology so we can provide women facing mastectomy with enhanced and effective options,” said Joe Woody, president and CEO of Acelity.

“Our new breast reconstruction offerings are designed to improve the clinician and patient experience, and build upon the rich history and renowned ALLODERM Tissue Matrix brand that began with the product’s development at LifeCell,” said Woody. “As part of the Acelity portfolio, we will continue to invest in innovation and expansion so that women who choose reconstruction, and the surgeons guiding their care, will have many more options available to them.”

Acelity
acelity.com

Related Articles Read More >

An illustration of a neurosurgeon using a robotic endoscope to remove a brain tumor.
MDO Nitinol Innovation Special Report
A photo of nitinol, a nickel-titanium alloy used for medical devices such as stents, heart valves, catheters and orthopedics.
What is nitinol and where is it used?
This Resonetics marketing image is an example of a example of complex nitinol component from the company.
Resonetics builds end-to-end nitinol capabilities: Here’s why that matters
A photo of the Cardiac Dimensions Carillon Mitral Contour System in a physician's hand.
How Cardiac Dimensions developed the Carillon Mitral Contour System — and makes the nitinol implant in-house
“mdo
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest medical device business news, application and technology trends.

DeviceTalks Weekly

See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
DeviceTalks

DeviceTalks is a conversation among medical technology leaders. It's events, podcasts, webinars and one-on-one exchanges of ideas & insights.

DeviceTalks

New MedTech Resource

Medical Tubing

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech100 Index
  • Medical Tubing + Extrusion
  • Medical Design Sourcing
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to our E-Newsletter
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2025 WTWH Media, LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media LLC. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Supplies and Components Index
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • MedTech Resources
    • Medtech Events in 2025
    • The 2024 Medtech Big 100
    • Medical Device Handbook
    • MedTech 100 Index
    • Subscribe to Print Magazine
    • DeviceTalks
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Podcasts
    • Print Subscription
    • Webinars / Digital Events
    • Whitepapers
    • Voices
    • Video
  • 2025 Leadership
    • 2024 Winners
    • 2023 Winners
    • 2022 Winners
    • 2021 Winners
  • Women in Medtech
  • Advertise
  • Subscribe